bell
The current prices are delayed by 15 mins, login to check live prices.
Vimta Labs Ltd share price logo

Vimta Labs Ltd

(VIMTALABS)

₹562.90%

as on 04:01PM, 21 Oct 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Vimta Labs Ltd Performance

  • Day's Low

    Day's High

    ₹540.1
    ₹568
  • 52 Week's Low

    52 Week's High

    ₹390.3
    ₹699.8
1 Month Return-1.22 %
3 Month Return+ 5.24 %
1 Year Return+ 7.49 %
Previous Close₹562.90
Open₹558.00
Volume37.67K
Upper Circuit-
Lower Circuit-
Market Cap₹1,247.98Cr

Vimta Labs Ltd Key Statistics

P/E Ratio30.36
PEG Ratio-9.23
Market Cap₹1,247.98 Cr
P/B Ratio3.12
EPS18.5
Dividend Yield0.45
SectorHealthcare
ROE13

Vimta Labs Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹1,247.98 Cr87.73%0.55₹41 Cr₹318 Cr
HOLD₹28,674.15 Cr31.42%0.55₹326 Cr₹2,694 Cr
NA₹57.15 Cr-13.19%0.51₹1 Cr₹59 Cr
BUY₹5,412.43 Cr17.77%0.50₹114 Cr₹670 Cr
BUY₹1,417.91 Cr-2.78%0.59₹41 Cr₹337 Cr

Vimta Labs Ltd Mutual Fund Holdings

About Vimta Labs Ltd

Vimta Labs Ltd., founded in 1984, is India's premier contract research and testing organization. They provide a wide range of services to several different industries such as pharmaceutical, biopharmaceutical, food, consumer goods, electronic-electrical, agrochemical, healthcare, medical devices and many others. These services range from drug discovery development, preclinical research, GLP and nonGLP clinical research, cGMP and non-GMP analytical services, preclinical research and testing for medical device companies, contract research and testing for agroscience companies, food testing and analytical development services, clinical diagnostics services, environmental regulatory services and more. Vimta was awarded ISO 9002 certification in 1994 and entered a joint venture in 1997 with ROSTEST Moscow, making an investment of 24 of the total Paidup Capital. In 2002, the Company began offering clinical diagnostics services. In 2020, Vimta acquired 100 Equity Shares of Emtac Laboratories Private Limited, making Emtac a wholly owned subsidiary of the Company. With a goal of expanding operations, they are in the process of constructing a five-times-larger facility in S.P.Biotech Park Genome Valley Hyderabad. By providing comprehensive services, certification and joint ventures, Vimta Labs Ltd. has become India's leading contract research and testing organization.

Share Price: ₹562.90 per share as on 21 Oct, 2024 04:01 PM
Market Capitalisation: ₹1,247.98Cr as of today
Revenue: ₹81.76Cr as on June 2024 (Q2 24)
Net Profit: ₹12.28Cr as on June 2024 (Q2 24)
Listing date: 15 Dec, 2005
Chairperson Name: S P Vasireddi
OrganisationVimta Labs Ltd
Headquarters
IndustryHealthcare
E-voting on sharesClick here to vote

Key events for Vimta Labs Ltd

  • Vimta Labs Q1 Results Show Increase in Profit Despite Decrease in Revenue - 18 Jul, 2024

    Vimta Labs reported a 2.07% decrease in revenue YoY but a 0.67% increase in profit. The company saw a 2.59% growth in revenue compared to the previous quarter, with EPS at ₹5.47. Vimta Labs delivered returns of 8.75% in the last week and has a consensus Buy rating from all one analyst covering the stock.

  • Vimta Labs to Host Annual General Meeting on July 18th - 12 Jul, 2024

    Vimta Labs CEO Harita Vasireddi's total remuneration includes a salary of ₹13.4m, similar to the industry average. The company's total shareholder return over the past three years was 74%, while its EPS grew by 24% per year. Revenue remained flat compared to last year.

Insights on Vimta Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 5.13% to 5.16% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 56.45% to 56.46% in Jun 2024 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, VIMTALABS stock has moved up by 1.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 80.18 Cr → 82.45 Cr (in ₹), with an average increase of 2.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Shree Ganesh Remedies Ltd has given 130.2% return, outperforming this stock by 34.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Shree Ganesh Remedies Ltd has given 66.1% return, outperforming this stock by 58.6%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 36.92% to 36.89% in Jun 2024 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 12.35 Cr → 12.28 Cr (in ₹), with an average decrease of 0.6% per quarter

Vimta Labs Ltd Financials

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹83.49Cr (-)₹73.41Cr (↓12.07%)₹81.68Cr (↑11.27%)₹79.69Cr (↓2.44%)₹81.76Cr (↑2.60%)
Net Income₹12.20Cr (-)₹6.33Cr (↓48.11%)₹10.13Cr (↑60.03%)₹12.35Cr (↑21.92%)₹12.28Cr (↓0.57%)
Net Profit Margin14.61% (-)8.62% (↓41.00%)12.40% (↑43.85%)15.50% (↑25.00%)15.02% (↓3.10%)
Value in ₹ crore
Details2021202220232024
Total Assets₹275.99Cr (-)₹308.87Cr (↑11.91%)₹362.08Cr (↑17.23%)₹396.02Cr (↑9.37%)
Total Liabilities₹81.67Cr (-)₹75.22Cr (↓7.90%)₹81.49Cr (↑8.34%)₹79.73Cr (↓2.16%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹24.37Cr (-)₹36.97Cr (↑51.70%)₹58.67Cr (↑58.70%)₹86.51Cr (↑47.45%)₹59.06Cr (↓31.73%)

Index Inclusions

BSE Healthcare

₹43,859.93

-0.86 (-378.57%)

BSE Small-Cap

₹55,648.96

-1.51 (-851.09%)

S&P BSE AllCap

₹10,734.78

-0.78 (-84.78%)

Vimta Labs Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
36.89%
-0.09
Foreign Institutions
5.16%
0.56
Mutual Funds
1.49%
0.00
Retail Investors
56.46%
0.02
Others
0%
-100.00

Vimta Labs Ltd Key Indicators

Details2021202220232024
Book Value Per Share (₹)87.92105.83127.33144.2
Details2021202220232024
Earning Per Share (₹)9.6818.6921.7718.5
Details20202021202220232024
Return On Equity %4.0211.5819.1918.413
Details2021202220232024
Return On Assets %7.7613.3813.310.36

Vimta Labs Ltd Valuation

Vimta Labs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (13.76x)

March 20, 2023

Today (30.36x)

October 18, 2024

Industry (95.46x)

October 18, 2024

Highest (36.42x)

September 9, 2024

LowHigh

Vimta Labs Ltd Earnings and Dividends

  • Vimta Labs Ltd Earnings Results

    Vimta Labs Ltd’s net profit jumped 0.66% since last year same period to ₹12.28Cr in the Q1 2024-2025. On a quarterly growth basis, Vimta Labs Ltd has generated -0.57% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Vimta Labs Ltd Dividends May,2024

    In the quarter ending March 2024, Vimta Labs Ltd has declared dividend of ₹2 - translating a dividend yield of 0.36%.

    Read More about Dividends

Vimta Labs Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Vimta Labs Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on Vimta Labs Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Vimta Labs Ltd shares.

Vimta Labs Ltd (VIMTALABS) share price today is ₹562.9

Vimta Labs Ltd is listed on NSE

Vimta Labs Ltd is listed on BSE

  • Today’s highest price of Vimta Labs Ltd is ₹568.
  • Today’s lowest price of Vimta Labs Ltd is ₹540.1.

PE Ratio of Vimta Labs Ltd is 30.36

PE ratio = Vimta Labs Ltd Market price per share / Vimta Labs Ltd Earnings per share

Today’s traded volume of Vimta Labs Ltd(VIMTALABS) is 37.67K.

Today’s market capitalisation of Vimta Labs Ltd(VIMTALABS) is ₹1247.98Cr.

Vimta Labs Ltd(VIMTALABSPrice
52 Week High
₹699.8
52 Week Low
₹390.3

Vimta Labs Ltd(VIMTALABS) share price is ₹562.9. It is down -19.56% from its 52 Week High price of ₹699.8

Vimta Labs Ltd(VIMTALABS) share price is ₹562.9. It is up 44.22% from its 52 Week Low price of ₹390.3